Knowledge of Constituent Ingredients in Enteral Nutrition Formulas Can Make a Difference in Patient Response to Enteral Feeding

Nutrition in Clinical Practice

Volumn 33, Issue 1, 2018, Pages 90-98

  Savino, Patricia ^a  

^a National Academy of Medicine of Colombia   (Colombia)

Author keywords

enteral formula; enteral nutrition; formulated food; intolerance; nutritional support

Indexed keywords

CARBOHYDRATE; FAT; FOOD INGREDIENT; MINERAL; PROTEIN; VITAMIN;

CALORIE; DIARRHEA; ENTERIC FEEDING; FOOD COMPOSITION; FOOD QUALITY; GASTROINTESTINAL TRACT; HUMAN; KNOWLEDGE; MACRONUTRIENT; MINERAL INTAKE; NONHUMAN; REVIEW; VITAMIN INTAKE; ADVERSE EVENT; CALORIC INTAKE; DIETARY REFERENCE INTAKE; ELEMENTAL DIET; ENERGY METABOLISM;

ENERGY INTAKE; ENERGY METABOLISM; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; NUTRIENTS; RECOMMENDED DIETARY ALLOWANCES;

EID: 85040985904     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533617724759     Document Type: Review

References (97)

1. de Aguilar-Nascimento JE, Kudsk KA. Early nutritional therapy: the role of enteral and parenteral routes. Curr Opin Clin Nutr Metab Care. 2008;11(3):255-260.
2. U.S. Food & Drug Administration. Medical foods guidance documents & regulatory information. http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/medicalfoods/default.htm. Accessed May 11 2017.
3. EUR-Lex. Commission Directive 1999/21/EC of 25 March 1999 on dietary foods for special medical purposes. http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:31999L0021. Accessed January 4, 2017.
4. Savino P. Legislacion de los alimentos con propositos medicos especiales, APME. Medicina (Bogotá). 2014;36(4):364-375.
5. Valentini L, Volkert D, Schütz D, et al. Suggestions for terminology in clinical nutrition. e-SPEN J. 2014;9(2):e97-e108.
6. Furst P, Stehle P. What are the essential elements needed for the determination of amino acid requirements in humans? J Nutr. 2004;134(6)(suppl):1558S-1565S.
7. Moore DR, Soeters PB. The biological value of protein. Nestle Nutr Inst Workshop Ser. 2015;82:39-51.
8. Moughan P, Gilani S, Rutherfurd S, Tomé D. Report of a Sub-Committee of the 2011 FAO Consultation on “Protein Quality Evaluation in Human Nutrition” on: The Assessment of Amino Acid Digestibility in Foods for Humans and Including a Collation of Published Ileal Amino Acid Digestibility Data for Human Foods. Rome, Italy: Food and Agriculture Organisation; 2012.
9. Keohane P, Silk D. Peptides and free amino acids. In: Rombeau JL, Caldwell MD, eds. Enteral and Tube Feeding. Philadelphia, PA: Saunders; 1984:44-59.
10. Soeters PB, van de Poll MC, van Gemert WG, Dejong CH. Amino acid adequacy in pathophysiological states. J Nutr. 2004;134(6)(suppl):1575S-1582S.
11. Burr G, Burr M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem. 1929;82:345-367.
12. Vanek VW, Seidner DL, Allen P, et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150-192.
13. Calder PC. Very long chain omega-3 (n-3) fatty acids and human health. Eur J Lipid Sci Technol. 2014;116(10):1280-1300.
14. Calder PC. A matter of fat. JPEN J Parenter Enteral Nutr. 2015;39(7):756-758.
15. Santacruz CA, Orbegozo D, Vincent JL, Preiser JC. Modulation of dietary lipid composition during acute respiratory distress syndrome: systematic review and meta-analysis. JPEN J Parenter Enteral Nutr. 2015;39(7):837-846.
16. Halmos EP, Muir JG, Barrett JS, et al. Diarrhoea during enteral nutrition is predicted by the poorly absorbed short-chain carbohydrate (FODMAP) content of the formula. Aliment Pharmacol Ther. 2010;32(7):925-933.
17. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31(8):874-882.
18. Halmos EP. Role of FODMAP content in enteral nutrition-associated diarrhea. J Gastroenterol Hepatol. 2013;28(suppl 4):25-28.
19. Barrett JS, Shepherd SJ, Gibson PR. Strategies to manage gastrointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr. 2009;33(1):21-26.
20. Yoon SR, Lee JH, Lee JH, et al. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J. 2015;14:116.
21. Rosset R, Surowska A, Tappy L. Pathogenesis of cardiovascular and metabolic diseases: are fructose-containing sugars more involved than other dietary calories? Curr Hypertens Rep. 2016;18(6):44.
22. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther. 2007;25(4):349-363.
23. Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008;27(2):120-145.
24. Whelan K, Schneider SM. Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol. 2011;27(2):152-159.
25. Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V. Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. JPEN J Parenter Enteral Nutr. 1994;18(6):486-490.
26. Spapen H, Diltoer M, Van Malderen C, et al. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial. Clin Nutr. 2001;20(4):301-305.
27. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211.
28. Lochs H, Allison SP, Meier R, et al. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2):180-186.
29. GovTrack. H.R. 3459 (100th): Orphan Drug Amendments of 1988. 1998. https://www.govtrack.us/congress/bills/100/hr3459/text. Accessed May 11, 2017.
30. Rose WC. The amino acid requirements of adult man. Nutr Abstr Rev. 1957;27(3):631-647.
31. Reeds PJ. Dispensable and indispensable amino acids for humans. J Nutr. 2000;130(7):1835S-1840S.
32. Dietary protein quality evaluation in human nutrition: report of an FAQ Expert Consultation. FAO Food Nutr Pap. 2013;92:1-66.
33. Soeters PB, de Jong CH, Deutz NE. The protein sparing function of the gut and the quality of food protein. Clin Nutr. 2001;20(2):97-99.
34. Wu G. Dietary protein intake and human health. Food Funct. 2016;7(3):1251-1265.
35. Marik PE. Feeding critically ill patients the right ‘whey’: thinking outside of the box. A personal view. Ann Intensive Care. 2015;5(1):51.
36. Paddon-Jones D, Coss-Bu JA, Morris CR, Phillips SM, Wernerman J. Variation in protein origin and utilization: research and clinical application. Nutr Clin Pract. 2017;32(1)(suppl):48S-57S.
37. Boirie Y, Dangin M, Gachon P, et al. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci USA. 1997;94(26):14930-14935.
38. Katsanos CS, Chinkes DL, Paddon-Jones D, et al. Whey protein ingestion in elderly persons results in greater muscle protein accrual than ingestion of its constituent essential amino acid content. Nutr Res. 2008;28(10):651-658.
39. Pennings B, Boirie Y, Senden JM, et al. Whey protein stimulates postprandial muscle protein accretion more effectively than do casein and casein hydrolysate in older men. Am J Clin Nutr. 2011;93(5):997-1005.
40. U.S. Dairy Export Council. Reference Manual for U.S. Milk Powders. Rev. ed. 2005. http://www.thinkusadairy.org/resources-and-insights/resources-and-insights/product-resources/reference-manual-for-us-milk-powders. Accessed May 11, 2017.
41. Hoppe C, Andersen GS, Jacobsen S, et al. The use of whey or skimmed milk powder in fortified blended foods for vulnerable groups. J Nutr. 2008;138(1):145S-161S.
42. U.S. Dairy Export Council. Reference Manual for U.S. Whey and Lactose Products. 2004. http://usdec.files.cms-plus.com/PDFs/2008ReferenceManuals/Whey_Lactose_Reference_Manual_Complete2_Optimized.pdf. Accessed May 11, 2017.
43. Damodaran S, Parkin KL, Fennema OR. Fennema’s Food Chemistry. 4th ed. Boca Raton, FL: CRC Press; 2007.
44. Food and Agriculture Organization (FAO). Protein quality evaluation. Report of the Joint FAO/WHO Expert Consultation. https://blog.priceplow.com/wp-content/uploads/fao-who-protein-quality-evaluation-1991.pdf. Accessed May 11, 2017.
45. Kreider R. Which protein is best for sports performance? In: Aluko RE, ed. Functional Foods and Nutraceuticals. New York, NY: Springer; 2016:42-52.
46. U.S. Department of Agriculture. Composition of foods raw, processed, prepared. USDA National Nutrient Database for Standard Reference. 2014. https://www.ars.usda.gov/ARSUserFiles/80400525/data/sr27/sr27_doc.pdf. Accessed May 11, 2017.
47. Cárdenas H, Gómez C, Díaz J, Camarena F. Evaluación de la calidad de la proteína de 4 variedades mejoradas de fríjol. Rev Cubana Aliment Nutr. 2000;14(1):22-27.
48. Ochoa Gautier JB, Martindale RG, Rugeles SJ, et al. How much and what type of protein should a critically ill patient receive? Nutr Clin Pract. 2017;32(1)(suppl):6S-14S.
49. Castellanos VH, Litchford MD, Campbell WW. Modular protein supplements and their application to long-term care. Nutr Clin Pract. 2006;21(5):485-504.
50. Yuh BE, Nazmy M, Ruel NH, et al. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol. 2012;62(5):806-813.
51. Ma C. Soybean: soy concentrates and isolates. In: Wrigley CW, Corke H, Seetharaman K, Faubion J, eds. Encyclopedia of Food Grains. Vol 3. New York, NY: Elsevier Science; 2016:482-488.
52. Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000;20(6C):4785-4792.
53. Hilmar Ingredients. Whey protein hydrolysates. http://www.hilmaringredients.com/products/whey_protein_product_bulletins/. 2016. Accessed May 11, 2017.
54. Silk DB, Grimble GK, Rees RG. Protein digestion and amino acid and peptide absorption. Proc Nutr Soc. 1985;44(1):63-72.
55. Rombeau JL, Caldwell MD. Enteral and Tube Feeding. Philadelphia, PA: Saunders; 1984.
56. Alexander DD, Bylsma LC, Elkayam L, Nguyen DL. Nutritional and health benefits of semi-elemental diets: a comprehensive summary of the literature. World J Gastrointest Pharmacol Ther. 2016;7(2):306-319.
57. Seres DS, Ippolito PR. Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic). Clin Nutr. 2017;36(3):706-709.
58. Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol (1985). 2009;107(3):987-992.
59. Benjamin J, Makharia G, Ahuja V, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial. Dig Dis Sci. 2012;57(4):1000-1012.
60. de Aguilar-Nascimento JE, Prado Silveira BR, Dock-Nascimento DB. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition. 2011;27(4):440-444.
61. Gramlich L, Meddings L, Alberda C, et al. Essential fatty acid deficiency in 2015: the impact of novel intravenous lipid emulsions. JPEN J Parenter Enteral Nutr. 2015;39(1)(suppl):61S-66S.
62. Calder PC. The 2008 ESPEN Sir David Cuthbertson Lecture: fatty acids and inflammation—from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr. 2010;29(1):5-12.
63. Rice TW. Gluttony in the intensive care unit: time to push back from the consensus table. Am J Respir Crit Care Med. 2013;187(3):223-224.
64. Swails WS, Kenler AS, Driscoll DF, et al. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. JPEN J Parenter Enteral Nutr. 1997;21(5):266-274.
65. Hise M, Brown J. Lipids. In: Mueller CM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2012:63-82.
66. Harbige LS. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids. 2003;38(4):323-341.
67. Roy CC, Bouthillier L, Seidman E, Levy E. New lipids in enteral feeding. Curr Opin Clin Nutr Metab Care. 2004;7(2):117-122.
68. FDA to allow CHD health claim for omega-3 fatty acids. http://www.medscape.com/viewarticle/783261. 2004. Accessed May 11, 2017.
69. Food and Nutrition Board, Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Press; 2005.
70. Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012;33(7):1482.e17-29.
71. U.S. National Library of Medicine. Lactose intolerance. 2017. https://ghr.nlm.nih.gov/condition/lactose-intolerance. Accessed May 11, 2017.
72. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25(2):252-258.
73. Hobbs L. Sweeteners from starch: production, properties and uses. In: BeMiller J, Whistler R, eds. Starch. 3rd ed. Burlington, MA: Academic Press; 2009:745-795.
74. White J. Sucrose, HCFS, and fructose: history, manufacture, composition, applications, and production. In: Rippe J, ed. Fructose, High Fructose corn Syrup, Sucrose and Health. New York, NY: Humana Press; 2014:13-36.
75. Corn Refiners Association. Nutritive sweeteners from corn. https://corn.org/wp-content/uploads/2009/12/NSFC2006.pdf. 2006. Accessed May 11, 2017.
76. Tappy L. How Dangerous is fructose? Medscape. 2015.http://www.medscape.com/viewarticle/852414#vp. Accessed January 4, 2017.
77. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30(2):165-174.
78. Gearry RB, Irving PM, Barrett JS, et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study. J Crohns Colitis. 2009;3(1):8-14.
79. Gibson PR, Muir JG. Non-nutritional effects of food: an underutilized and understudied therapeutic tool in chronic gastrointestinal diseases. J Gastroenterol Hepatol. 2013;28(suppl 4):37-40.
80. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75.e65.
81. Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol. 2014;12(10):1592-1600.
82. Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41(12):1256-1270.
83. Thomas JR, Nanda R, Shu LH. A FODMAP diet update: craze or credible? Nutrition issues in gastroenterology, series #112. Pract Gastroenterol. 2012;36(12):37-46.
84. Shepherd S, Gibson P. The Monash University Low FODMAP Diet. 4th ed. Melbourne, Australia: Monash University; 2012.
85. Halmos EP, Liels KL, Rosella O, et al. Enteral and oral nutritional supplement formulas deliver laxative doses of FODMAPs which cannot be predicted by ingredients lists. J Gastroenterol Hepatol. 2011;26(suppl 4):73.
86. Ingenbleek Y, Bernstein LH. Plasma transthyretin as a biomarker of lean body mass and catabolic states. Adv Nutr. 2015;6(5):572-580.
87. Raguso CA, Dupertuis YM, Pichard C. The role of visceral proteins in the nutritional assessment of intensive care unit patients. Curr Opin Clin Nutr Metab Care. 2003;6(2):211-216.
88. Shenkin A. Serum prealbumin: is it a marker of nutritional status or of risk of malnutrition? Clin Chem. 2006;52(12):2177-2179.
89. World Health Organization. Sugars intake for adults and children guideline. http://www.who.int/nutrition/publications/guidelines/sugars_intake/en/. 2015. Accessed May 11, 2017.
90. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120(11):1011-1020.
91. Kearns CE, Schmidt LA, Glantz SA. Sugar industry and coronary heart disease research: a historical analysis of internal industry documents. JAMA Intern Med. 2016;176(11):1680-1685.
92. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract. 2006;21(5):438-449.
93. Ben-Hamouda N, Charriere M, Voirol P, Berger MM. Massive copper and selenium losses cause life-threatening deficiencies during prolonged continuous renal replacement. Nutrition. 2017;34:71-75.
94. Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013;381(9864):385-393.
95. Thibault R, Graf S, Clerc A, et al. Diarrhoea in the ICU: respective contribution of feeding and antibiotics. Crit Care. 2013;17(4):R153.
96. de Brito-Ashurst I, Preiser JC. Diarrhea in critically ill patients: the role of enteral feeding. JPEN J Parenter Enteral Nutr. 2016;40(7):913-923.
97. Reintam Blaser A, Deane AM, Fruhwald S. Diarrhoea in the critically ill. Curr Opin Crit Care. 2015;21(2):142-153.